GlycoMimetics Inc (NASDAQ:GLYC) does about 1.70M shares in volume on a normal day but saw 2628984 shares change hands in the recent trading day. The company now has a market cap of 11.40M USD. Its current market price is $0.18, marking a decrease of -8.88% compared to the previous close of $0.19. The 52 week high reached by this stock is $0.63 whilst the lowest price level in 52 weeks is $0.14.
The consensus objective for the share price is $0.50, suggesting that the stock has a potential upside of 64.0% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Hold the stock.
CapitalOne initiated its price target at $12.
The current price level is -22.67%, -22.03%, and -28.12% away from its SMA20, SMA50, and SMA200 respectively, with the GLYC price moving above the 50-day SMA on current market day. GlycoMimetics Inc (GLYC) stock is down -12.57% over the week and -27.18% over the past month. Its price is -29.08% year-to-date and -34.83% over the past year.
To reach the target analysts have set, the stock logically needs to grow 64.0 percent from here.
Outstanding shares total 64.53M with insiders holding 2.66% of the shares and institutional holders owning 47.76% of the company’s common stock. The company has a return on investment of -873.60% and return on equity of -182.66%. The beta has a value of 1.59. Price to book ratio is 3.38.
